13

Congratulations to Associate Professor Sudarshini Ramanathan who was awarded over $2.8 million in MRFF funding to identify optimal treatment of Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) at onset and relapse, to reduce disease activity and improve outcomes.